Recerca > Càncer

Grup de recerca de biomarcadors en càncer (GReBiC)

Nombre de publicacions
495
Cercador de publicacions
  • Valladares-Ayerbes, M; Fonseca, MT; de Prado, JV; Inga-Saavedra, E; Gil, S; Suarez, BG; Garcia-Paredes, B; Salud, A; Herrero, FR; Fernandez, MS; Garcia-Alfonso, P; Lopez-Lopez, R; Monteagudo, RF; Sastre, J; Diaz-Rubio, E; Aranda, E

    Circulating RNA detection, circulating tumor cells count, and molecular tumor profiling in a cohort of untreated metastatic colorectal cancer: A prospective multicenter ancillary study to the randomized VISNU trials

    ANNALS OF ONCOLOGY 32 131-132. .

    [doi:10.1016/j.annonc.2021.05.154]

  • Mummadi SR; Porcel JM

    Ambulatory management of secondary spontaneous pneumothorax: a mirage, or a solution on the horizon?

    EUROPEAN RESPIRATORY JOURNAL 57 -. .

    [doi:10.1183/13993003.00003-2021]

  • Sorolla MA; Sorolla A; Parisi E; Salud A; Porcel JM

    Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions.

    Cancers 13 -. .

    [doi:10.3390/cancers13112798]

  • Vicente-Pascual M; Molins-Rojas C; Rosas-Soto K; Murata-Yonamine EP; Vázquez-Justes D; Purroy F; Traveset-Maeso A

    Bilateral Optic Neuritis Secondary to Immune Etiology by anti-PD-L1 Antibody.

    JOURNAL OF NEURO-OPHTHALMOLOGY 41 177-179. .

    [doi:10.1097/WNO.0000000000001029]

  • Porcel JM; Murata P; Porcel L; Bielsa S; Pardina M; Salud A

    Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer.

    Pleura and Peritoneum 6 75-81. .

    [doi:10.1515/pp-2020-0152]

  • Porcel JM

    Dr. Richard W. Light (1942-2021).

    ARCHIVOS DE BRONCONEUMOLOGIA -. .

    [doi:10.1016/j.arbr.2021.05.024]

  • Vidal, J; Casadevall, D; Bellosillo, B; Pericay, C; Garcia-Carbonero, R; Losa, F; Layos, L; Alonso, V; Capdevila, J; Gallego, J; Vera, R; Salud, A; Martin-Richard, M; Nogue, M; Cillan, E; Maurel, J; Faull, I; Raymond, V; Fernandez-Martos, C; Montagut, C

    Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD1402 Trial

    CLINICAL CANCER RESEARCH 27 2890-2898. .

    [doi:10.1158/1078-0432.CCR-20-4769]

  • Bagueste, G; Porcel, JM

    Pleural Infection Caused by Nocardia farcinica: Two Cases and Review of the Literature

    CUREUS JOURNAL OF MEDICAL SCIENCE 13 -. .

    [doi:10.7759/cureus.14697]

  • Martin, M; Zielinski, C; Ruiz-Borrego, M; Carrasco, E; Turner, N; Ciruelos, EM; Munoz, M; Bermejo, B; Margeli, M; Anton, A; Kahan, Z; Csoszi, T; Casas, MI; Murillo, L; Morales, S; Alba, E; Gal-Yam, E; Guerrero-Zotano, A; Calvo, L; de la Haba-Rodriguez, J; Ramos, M; Alvarez, I; Garcia-Palomo, A; Bartlett, CH; Koehler, M; Caballero, R; Corsaro, M; Huang, X; Garcia-Saenz, JA; Chacon, JI; Swift, C; Thallinger, C; Gil-Gil, M

    Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL

    ANNALS OF ONCOLOGY 32 488-499. .

    [doi:10.1016/j.annonc.2020.12.013]

  • Sastre, J; Garcia-Alfonso, P; Vieitez, JM; Cano, MT; Rivera, F; Reina-Zoilo, JJ; Salud-Salvia, A; Quintero, G; Robles-Diaz, L; Safont, MJ; La Casta, A; Gil, S; Polo, E; Asensio-Martinez, E; Garcia-Paredes, B; Lopez, RL; Guillot, M; Valladares-Ayerbes, M; Aranda, E; Diaz-Rubio, E

    Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and < 3 baseline circulating tumour cells: the randomised phase II VISNU-2 study

    ESMO Open 6 -. .

    [doi:10.1016/j.esmoop.2021.100062]

  • Cudos, AG; Murillo, SM; Subirats, OP; Galindo, AR; Rodriguez, JV; Guzman, DRS; Villellas, FV; Morales, CC; Olive, JM; Martinez, EI

    Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

    BREAST 56 52-53. .

  • Golden E; Rashwan R; Woodward EA; Sgro A; Wang E; Sorolla A; Waryah C; Tie WJ; Cuyàs E; Ratajska M; Kardas I; Kozlowski P; Johnstone EKM; See HB; Duffy C; Parry J; Lagerborg KA; Czapiewski P; Menendez JA; Gorczynski A; Wasag B; Pfleger KDG; Curtis C; Lee BK; Kim J; Cursons J; Pavlos NJ; Biernat W; Jain M; Woo AJ; Redfern A; Blancafort P

    The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

    Nature Communications 12 1920-1920. .

    [doi:10.1038/s41467-021-22101-7]